Filing Details
- Accession Number:
- 0001209191-15-001080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-01-05 16:56:36
- Reporting Period:
- 2015-01-02
- Filing Date:
- 2015-01-05
- Accepted Time:
- 2015-01-05 16:56:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1218629 | S Leonard Schleifer | 777 Old Saw Mill River Rd Tarrytown NY 10591 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-01-02 | 1,500 | $0.00 | 1,500 | No | 4 | C | Indirect | by Trust for Son |
| Common Stock | Disposition | 2015-01-02 | 397 | $408.64 | 1,103 | No | 4 | S | Indirect | by Trust for Son |
| Common Stock | Disposition | 2015-01-02 | 300 | $409.28 | 803 | No | 4 | S | Indirect | by Trust for Son |
| Common Stock | Disposition | 2015-01-02 | 403 | $410.47 | 400 | No | 4 | S | Indirect | by Trust for Son |
| Common Stock | Disposition | 2015-01-02 | 200 | $412.23 | 200 | No | 4 | S | Indirect | by Trust for Son |
| Common Stock | Disposition | 2015-01-02 | 100 | $413.88 | 100 | No | 4 | S | Indirect | by Trust for Son |
| Common Stock | Disposition | 2015-01-02 | 100 | $416.00 | 0 | No | 4 | S | Indirect | by Trust for Son |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Indirect | by Trust for Son |
| No | 4 | S | Indirect | by Trust for Son |
| No | 4 | S | Indirect | by Trust for Son |
| No | 4 | S | Indirect | by Trust for Son |
| No | 4 | S | Indirect | by Trust for Son |
| No | 4 | S | Indirect | by Trust for Son |
| No | 4 | S | Indirect | by Trust for Son |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Class A Stock | Disposition | 2015-01-02 | 1,500 | $0.00 | 1,500 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 15,775 | No | 4 | C | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,650 | Indirect | By 401(k) Plan |
| Common Stock | 42,087 | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Class A Stock | $0.00 | 1,710,790 | 1,710,790 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 1,710,790 | 1,710,790 | Direct |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 397 shares of Company stock on January 2, 2015 at prices ranging from $408.33 to $408.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price.
- Represents volume-weighted average price of sales of 300 shares of Company stock on January 2, 2015 at prices ranging from $409.13 to $409.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price.
- Represents volume-weighted average price of sales of 403 shares of Company stock on January 2, 2015 at prices ranging from $410.07 to $410.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on January 2, 2015 at prices ranging from $412.13 to $412.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on January 2, 2015 at each separate price.
- Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events or upon election of the shareholder.
- These shares of Class A Stock are presently convertible and such conversion feature does not expire.
Billionaire Hedge Funds
